Melrose Industries (LON: MRO) has been one of the most successful companies that started out on AIM. It is one of the few that has managed to move into the FTSE 100 index after switching to the Main Market. That followed a series of acquisitions. On 20 April there will be a demerger that will split Melrose into the aerospace business and Dowlais.
At 160.5p, Melrose is valued at £6.5bn. Net debt was £1.14bn at the end of 2022. Existing investors will receive one new share for three existing shares in a share consolidation – equivalent to 481.5p - and then shareholders will receive one Dowlais s...
Aquis weekly movers: NFT crypto asset valuation
NFT Investments (LON: NFT) says that its crypto assets are worth 2.77p a share at 2 April. The majority is in Bitcoin and Ethereum.
Six Capital for Colleagues (LON: CFCP) directors and people closely associated with them have bought a total of 709,064 shares.
Invinity Energy Systems (LON: IES) says it has delivered more than 11.4 MWh of batteries so far in 2023. There are more batteries due to be delivered to projects in Australia and California.
Gunsynd (LON: GUN) reported a realised and unrealised loss of £305,000 in the six months to January 2023. Net assets were £3.28m, including cash of £304,000.
Ananda Developments (LON: ANA) chief executive Melissa Sturgess sold 145 million shares at 0.3p each. They were acquired by Palace Trading Investments, which is owned by Tiger Trust, and she is the sole beneficiary. That means that she is still interested in these shares.
Aquis Exchange (LON: AQX) has launched Aquis Equinox, which is a regulated market-grade 24/7 matching engine. Rival exchange models need to be shut down to perform resets and maintenance. Aquis Equinox will be offered via the cloud or on-premise. Chairman Glenn Collinson bought 7,500 shares at 400p each and 5,000 shares at 412p each. Chief executive Alasdair Haynes acquired 10,000 shares at 390p each.
Marula Mining (LON: MARU) has observed high grade graphite mineralisation at Nyorinyori project in Tanzania. Results from sampling are expected in the second quarter of 2023. There have also been two major graphite prospects observed at the Bagamoyo project. Further mining licences could be added to the project. Site works at the 75%-owned Kinusi copper project are just starting and there are plans to install a copper processing plant. Brahma Finance has converted £265,000 of loan notes at 2p a share.
RentGuarantor Holdings (LON: RGG) increased revenues by 92% in the three months to March 2023.
==========
Fallers
TruSpine Technologies (LON: TSP) has terminated a consultancy agreement with a company that provided the services of Frank Boehm, who was the inventor of some of the company’s spinal stabilisation systems technology. He is challenging the company’s ownership of the IP.
Several SunNOx Group (LON: SNOX) shareholders have entered into option agreements with RemNOx over 24 million shares at 30p each. The option lasts until 29 September. That could take the RemNOx stake to 29.8%.
KR1 (LON: KR1) says NAV was 68.22p a share at the end of February 2023, up from 30.6p a share at the end of June 2022.
Wishbone Gold (LON: WSBN) says that it appears that the Red Setter project is a potential analogue of the 26 million plus ounce Telfer deposit 15kn north east of the project.
AIM weekly movers: Block Energy cash generation boost
Block Energy (LON: BLOE) says that its financial position has improved, and the salary sacrifice scheme started in April 2020 has come to an end. Cash generation from the WR-B01Za, which is producing 274 barrels of oil/day, is important and there is optimism about further wells. The share price rose 56.8% to 1.45p.
Scirocco Energy (LON: SCIR) says that 50%-owned investee company Energy Acquisitions Group, which operates an anaerobic digestor plant in Northern Island, had a strong final quarter of 2022. In the three months to December 2022, the Greenan anaerobic plant improved year-on-year revenues from £334,000 to £423,000 and EBITDA was 48% higher at £231,000. The construction of a biofertilizer plant should start in the second quarter of 2023. This success could be repeated on other sites. The share price is 50% ahead at 0.45p.
Shares in Saietta Group (LON: SED) soared on the back of the largest ever order for its eDrive systems. They are 42.2% higher at 63p. That is still much lower than the July 2021 placing price of 120p. The £5m order is for 3,000 bespoke systems based on the AFT140 motor from Nasdaq-listed urban delivery vehicles manufacturer AYRO. Saietta is exclusive supplier for the Vanish vehicle launched in February. First deliveries will be in the autumn and the full number delivered by the end of 2024.
Restaurants operator Fulham Shore (LON: FUL) is recommending a 14.15p a share cash bid by Tokyo-based TORIDOLL Holdings. The share price jumped 36.1% to 13.95p. It has been a tough period for small restaurant groups. The bidder has revenues of around £1bn and already has European interests. It works with specialist private equity firm Capdesia in Europe. The takeover will enable greater expansion of the Franco Manca and The Real Greek brands.
==========
Fallers
A heavily discounted share placing raising £1.5m at 1p a share hit the share price of Light Science Technologies (LON: LST) knocking it by 67.5% to 1.3p, making it the worst performer on the shortened week. The October 2021 placing price was 10p. There is also a retail offer of up to 50 million more shares via the Winterflood Retail Access Platform and this closes on 14 April. The cash will provide working capital for the controlled environment agriculture technology operations.
Tungsten West (LON: TUN) is restructuring the operations of its Hemerdon tungsten and tin project in Devon. Costs will be cut, and surplus assets sold. Concentrate at the site will be sold. Project funding is being discussed. A convertible note issue raised £7m and an open offer could raise up to £2m. This should help to progress the Hemerdon project. The share price slumped 55.8% to 4.75p. Trading in the shares commenced in October 2021 at 61.25p.
Nanosynth (LON: NNN) warned late on Thursday that it is running out of cash and the share price dived by 47.4% to 0.1p. A VAT rebate will help, but it only has enough cash up until June. An R&D tax credit claim could extend that timeframe, but more cash will need to be raised. Potential funding options are being considered.
Linear generator technology developer Libertine Holdings (LON: LIB) shares declined after management revealed delays in development work that mean that 2022-23 revenues could be up to £400,000 lower than the expected £1.32m. The share price slipped 37.8% to 11.5p. Management believes it has sufficient cash for its requirements, while it seeks to sign up partners.
Titon chief executive leaves after less than one year
Less than one year after joining Titon Holdings (LON: TON) Alexandra French has stepped down as chief executive. This was announced after the market closed and followed Jupiter Investment Management revealing that it has sold its 11.3% stake.
The share price has fallen from 90p to 70p (65p/75p) over the past 12 months. Last September, Rockwood Strategic (LON: RKW) acquired an 8.75% stake in the window ventilators and parts manufacturer and it is the largest shareholder until the fate of the Jupiter stake is known.
Rockwood Strategic may even be the buyer of all or some of these shares. It is an activist investor and may have been involved in the management change.
The announcement says that Alexandra French agreed with the board that she should step down. The search for a replacement will start as soon as possible. A new commercial director joins in May.
Margins are improving, but another small loss is expected in the year to September 2023. Net cash is £1.7m and net tangible assets are £15m. The market capitalisation is £7.9m. This discount to net tangible assets will be one thing that has attracted Rockwood Strategic.
Allergy Therapeutics secures financing
Allergy Therapeutics (LON: AGY) is raising £40.75m from Skygem and Southern Fox, plus an open offer to shareholders underwritten by Skygem. The issue price is 1p. This could require a mandatory bid for the allergy treatments developer from Skygem if its stake goes above 30%. However, the AIM quotation will be maintained.
In September 2022, the two investors subscribed £7m at 20p a share. The mandatory bid would be at 1p, though. Southern Fox, which could end up with 27.5% of Allergy Therapeutics, would not accept any bid. A loan facility of £40.75m has been set up until the authorities approve the new investment.
Skygem is an indirect subsidiary of funds managed by Asian private equity firm ZQ Capital Management and it was set up to buy shares in Allergy Therapeutics in 2019. Skygem currently owns 25.6% and it believes it can help in Asian markets.
Production problems mean that 2022-23 revenues will be below expectations. The manufacturing facilities require investment, and it will be difficult to gain significant funding from elsewhere.
AIM-quoted Allergy Therapeutics shares are suspended at 6.25p. The cash will enable the accounts for the year to June 2022 and the subsequent interims to be published. NatWest will not allow the use of the revolving debt facility because of the loss being made.
Interim revenues fell from £48.7m to £39.9m and higher R&D spending has moved the company into loss.
FTSE 100 gains ahead of Easter break
The FTSE 100 was set to finish the week on a high as the index rallied into the close ahead of the Easter break. Higher oil majors again provided a boost to the index in what was a broad rally with cyclical sectors leading the charge.
The FTSE 100 was 0.9% higher at the time of writing while the German Dax added 0.3%. US stocks were flat to slightly down after a softer session overnight.
The concerns about the health of US economy evident in US stocks were shaken off in Europe where the focus was on oil prices and the relative value of cyclical names after the recent sell off.
Many European equity exchanges will be closed tomorrow when March’s Non-Farm Payrolls will be released. The US has recorded strong job creation so far in 2023 – but there are worries this will start to slow and shows signs of a contractionary environment.
“The market will look to the March number and also any revisions to January and February to take the temperature of the US economy. Upward revisions usually indicate strength, downward revisions can be suggestive of a weakening or loss of economic momentum,” said Danni Hewson, head of financial analysis at AJ Bell.
A disappointing set of US manufacturing data yesterday led to a softer session for US stocks overnight. US manufacturing PMI data for the month of March declined demonstrating a slow down in US economic activity.
“Following a weak readout for US manufacturing earlier in the week the US Services PMI index fell from 51.2 in March from 55.1 in February and well below consensus forecasts of 54.5. There’s further signs too of a weakening US labour market with private sector hiring rising by just 145,000 in March, down from 261,000 in February and below the estimate for 210,000,” said Derren Nathan, head of equity research, Hargreaves Lansdown.
Many economists are now predicting a US recession, the timing of which varies dramatically.
FTSE 100 strength
Notwithstanding concerns about the US economy, UK and European shares were upbeat and showed a rare disregard for happenings across the pond.
This may be down to lower volumes ahead of the holidays. Nonetheless, there were plenty of reasons for cheer across FTSE 100 stocks.
Shell shares gained after providing a positive insight into Q1 activities. Shell shares were 2% higher on strength in their LNG business and hopes of strong cash generation.
Admiral Group, BT and Unite Group were among the top risers as they continued recent rallies.
UK banks Lloyds, Barclays and Natwest built on their recoveries from the recent banking crisis. Barclays was trading above 150p while Lloyds looked set to attack 50p.
Shell shares rise after Q1 update
Shell doesn’t leave their investors in the dark for long and this morning issued an insight into performance for Q1 ahead of Q1 results set for release 4th May.
The main takeaways from the update were higher LNG volumes and earnings, and the front loading of taxes. LNG production is expected to rise to between 930 – 970 kboe/d in Q1, an increase on Q4’s 917 kboe/d.
Operating expenditure is expected to be lower across their oil and gas business which bodes well for cash generation in the first quarter 2023.
Shell shares were 2% higher at the time of writing.
“In its usual teaser ahead of quarterly results Shell is flagging a big loss – but there is a reason investors are brushing this news off,” said Danni Hewson, head of financial analysis at AJ Bell.
“The anticipated loss is a quirk of accounting – reflecting one-off tax charges which could well be the result of booking the impact of future windfall taxes upfront. Based on the performance of the company’s other business units you would still expect Shell to be generating plenty of cash to fund its dividend.
“Volumes in its liquefied natural gas business are expected to be higher and its oil products division is also performing well.
“A recent spike in oil prices on OPEC production cuts should be giving Shell a boost, although not one which will be reflected in these results.”

